COVID-19 detection kits have proven to be extremely crucial in limiting the spread of the virus and providing immediate medical attention to patients

The COVID-19 Detection Kit is an in vitro multiplex PCR assay that is designed for qualitative SARS-CoV-2 virus nucleic acid detection in upper and lower respiratory specimens.

                           COVID-19 detection kits

The COVID-19 Detection Kit is an in vitro multiplex PCR assay that is designed for qualitative SARS-CoV-2 virus nucleic acid detection in upper and lower respiratory specimens. The COVID-19 detection kits are only approved for use in laboratories that have been certified under the Emergency Use Authorization granted by the U.S. Food and Drug Administration (FDA). The kit is not for use in routine clinical practice. The kit is not appropriate for screening or diagnosis of patients. Despite this warning, the COVID-19 detection kits remain the gold standard for determining the presence of the disease. This is a critical first step in managing a COVID-19 outbreak. According to the World Health Organization (WHO), as of November 2021, over 258 million cases of COVID-19 have been confirmed with over 5 million people dying due to the same.


While testing remains a crucial step in the COVID-19 pandemic, new technologies are advancing the field. The Molecular point-of-care test is a rapid, simple method that can be used in many settings. It works by amplifying a portion of the virus genome. This method can reduce the time it takes for a test to return a positive result to a laboratory. COVID-19 detection kits are a non-invasive test for coronavirus. The test will detect the COVID-19 protein RNA that is found on the surface of the virus. The antigen tests are the most reliable for patients who have recently been exposed to the virus. These tests are often accurate and fast, and they can be used to confirm the diagnosis of HIV. Once a positive result is confirmed, a patient may be prescribed a COVID-19 antigen vaccine.


A COVID-19 test is usually the most accurate test when it comes to HIV infection. This type of test involves detecting bits of proteins on the surface of the virus. The antigen test is most accurate if performed within a few days of the onset of symptoms. This type of COVID-19 is a dangerous virus that can spread to other parts of the body. Therefore, it is very important to know the symptoms and get the right treatment. Recently, in May 2021, Cipla in partnership with Ubio Biotechnology Systems launched real-time COVID-19 testing an RT-PCR kit named ViraGen.

Comments

Post a Comment

Popular posts from this blog

Label-Free Array Systems; Best Suited For Drug Discovery, Rapid Diagnosis, and Security Applications

Image
                                                                                                         Label-Free Array Systems Label-free array systems are widely used in the drug discovery process by biotechnology and pharmaceutical companies. A system works on principle of optical interferometry, impedance-based assays, and refractive index to identify and validate new molecules as the possible drug candidates. Moreover, the system helps to reduce the cost and time for drug identification and validation process. In the past few years, label-free array systems have taken center stage as an effective research tool in all major clinical drug discovery processes. Label-free array systems comprises two types of biosensors, namely optical and impedance-based biosensors, including techniques such as bio-layer interferometry, isothermal titration calorimetry, surface plasmon resonance, and others. Of which, surface plasmon resonance is the most commonly used technique. The main advantag
Read more

Rising adoption of AI to boost Smart Home as a service Market Growth

Image
Smart Home as a service Market Smart Home as a service Market by System (Lighting Control, Home Monitoring/Security, Thermostat, Smart Appliances, Video Entertainment), Channel (Retailers, OEM, E-commerce) and By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030 The global Smart Home as a Service Market is estimated to be valued at US$ 2,483.48 million in 2023, and is expected to exhibit a CAGR of 16.98 % over the forecast period, as highlighted in a new report published by Coherent Market Insights. Market Overview: Smart home as a service or also known as ShaaS is a kind of service where as a substitute of user, service provider chooses, installs, manages, upgrades, and programs smart home devices. Smart home as a service utilizes the subscription-based business designs with monthly payment from users. Competitive Landscape: Key players involved in the growth of the global Sm
Read more

Cataract Surgery Devices have significantly improved over the years with rising emphasis on the safety of the patient and accuracy of the surgery

Image
                                                          Cataract Surgery Devices Cataract surgery involves replacing the natural lens of the eye with an intraocular lens. The condition causes a cloudy vision. The natural lens of the eye has become opaque. In order to correct this problem, a person may need this procedure. The surgery is commonly known as a lens replacement. Although it is not a traumatic procedure, it can be painful and requires several sessions. However, it is not the only option for this condition. A high-frequency ultrasound device is used during cataract surgery. The surgeon will remove the lens with the use of a suction device. The surgery can be done on the day of the procedure. A temporary prescription eye shield will help to recover faster. After the procedure, the patient will still need to wear glasses or contacts. One can even start a new activity right after the surgery. The process of recovery varies depending on the specific needs and the extent of the
Read more